Ближайший уровень поддержки по SPY – 201.25 уровень сопротивления – 201.75



Сегодня крупнейшее IPO компании Alibaba (тикер BABA). Подробнее можно почитать тут: gtstocks.com/forum/viewtopic.php?f=38&t=31&p=61#p61

CPA покупка выше 77.50

CRR смотрим на откат после гэпа

Gapping up/down: CNQR +19% after merger with SAP (-4%), YHOO +2% ahead of BABA IPO, GLNG +4% after upgrade; TIBX, VMI, and ORCL -3% after earnings, ESI -15% following Wells Notice, CRR -6% after dg at GS Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: PDEX +28.6%

M&A news: CNQR +19.4% (to be acquired by SAP subsidiary, SAP America, for $129 per share), DRC +12.1% (following reports that company may receive $80/share bid from Siemens (SI)), LULU +1.6% (Keybanc discussed VFC exec comments suggesting possible LULU deal)

Select Apple value chain related names showing strength: RFMD +1.3%, SWKS +1%, AVGO +0.8%, NXPI +0.7%

Select China related names showing strength ahead of BABA IPO: WB +1.7%, JD +1.1%, BIDU +0.8%

Other news: NAVB +10.5% (confirms it received Orphan Drug Designation from FDA for Use of Lymphoseek in Head and Neck Cancers), MCP +5.3% (Oaktree Capital Mgmt discloses 9.1% stake in 13G), HIMX +4.2% (climbed higher into the close after analyst suggested Google may replace Samsung OLED displays with Himax), JBLU +4.2% (announced that Robin Hayes, the company's current President, will succeed Dave Barger as CEO, effective February 16, 2015), INVN +3.4% (reports indicate that iPhone 6 contains InvenSense MP67B 6-axis Gyroscope), EMES +2.6% (initiated with a Buy at Goldman), MGA +2.5% (announces cooperation regarding regulatory investigation), SHLD +2.3% (Fairholme Capital Management disclosed 24% active stake in 13D filing), RBS +2.1% (following result of Scottish referendum), YHOO +1.9% (trading higher in advance of BABA IPO, also target raised to $48 from $44 at Piper Jaffray, tgt raised to $43 from $39 at Cantor Fitzgerald), WEN +1.7% (Trian Fund Management reports 24.39% stake in amended 13/D filing), RAD +1.5% (favorable commentary on Thursday's Mad Money), AMD +1.3% (co and Synopsys expanded their IP partnership), GILD +1.2% (announces European Commission granted marketing authorization for co's Zydelig), VOD +0.8% (in relation to Vivendi (VIVHY) authorized agreement with Telefonica (TEF) concerning the acquisition of GVT), GSK +0.8% (announces China investigation outcome; will pay a fine of GBP297 mln), HTZ +0.8% (China Partner, CAR Inc. announces IPO), NFLX +0.5% (officially launches in France, Germany, Austria, Switzerland, Belgium And Luxembourg)

Analyst comments: GLNG +4.5% (target raised to $110 from $75 at BofA/Merrill), FRAN +2.6% (upgraded to Buy from Neutral at Buckingham Research), AEO +2.4% (upgraded to Buy from Neutral at Goldman), NVAX +2.2% (assumed with an Outperform at Wedbush), ZION +1.2% (upgraded to Strong Buy from Outperform at Raymond James), VFC +1% (upgraded to Buy from Hold at KeyBanc Capital Mkts), FEYE +1% (target raised to $40 from $36 at Piper Jaffray), AMZN +0.8% (target raised to $435 at RBC Capital Mkts)

Gapping down
In reaction to disappointing earnings/guidance: TIBX -3.6%, VMI -3.2%, ORCL -2.8%, (also appoints Larry Ellison Executive Chairman and CTO; Larry Ellison steps down as CEO )

M&A news: SAP -4.1% (acquiring CNQR for $129 per share)

Select metals/mining names showing weakness: GFI -1.6%, RIO -1.5%, MT -1.3%, HMY -1.2%, IAG -0.9%, BHP -0.7%

Other news: ESI -15% (disclosed it received Wells Notice), QRHC -14% (announced proposed public offering), EROC -4.5% (filed for ~53.34 mln unit offering of common units representing limited partner interests by selling unitholders), STM -3.9% (still checking), CLDT -3.1% (launched public offering of 5 mln common shares), BXMT -2.7% (announces public offering of class A common stock), SNE -2.2% (continued weakness following guiding earlier this week), GLUU -1.9% (filed for ~9.98 mln share common stock offering by selling shareholders), TOT -1.5% (received offer from Arkema (ARKAY) to acquire its Bostik affiliate; offer values Bostik at EUR1.74 bln), MITK -0.8% (disclosed Chief Marketing Officer, Scott Carter, is leaving the co)

Analyst comments: CRR -6.3% (downgraded to Sell from Neutral at Goldman), AUXL -4% (downgraded to Neutral from Buy at Goldman), SDRL -1.2% (downgraded to Underperform from Neutral at Exane BNP Paribas)

Оригинал статьи: gtstocks.com/analytics-19-09-2014.html

Ближайший уровень поддержки по SPY – 196.00 уровень сопротивления – 196.50



AMGN смотрим на откат вниз

WHR продажа от 150

MHK покупка выше 140

MIDD покупка выше 88

HAR покупка выше 113

SVXY покупка выше 84

GILD смотрим на продажу, ГЭП на премаркете

TAP покупка выше 75

Gapping up/down: JCP +2% after earnings, MNST +20% on KO strategic partnership, ACHN +17% after Phase 2 data; JD and JWN -4% after earnings; ICPT -2% after initiation with Underperf

Gapping up
In reaction to strong earnings/guidance: DQ +10.8%, VRML +10.7%, RIOM +9.5%, CEP +7.9%, LIME +7.6%, YOD +7.5%, SKBI +5.6%, WYY +5.4%, SINA +5.2%, ADSK +4.4%, HTM +4.3%, AMAT +3.8%, XON +3.6%, AGRX +2.7%, ROX +2.7%, CHL +2.7%, UPIP +2.5%, LEI +2%, JCP +2%, KITE +1.7%, MNDL +1.4%, AEG +1.2%, SAND +1%, EL +0.8%, A +0.7%.

M&A news: MNST +20.3% (Monster Beverage and Coca-Cola enter into long-term strategic partnership), KO +1.8% (Monster Beverage and Coca-Cola enter into long-term strategic partnership).

Other news: ACHN +17.5% (achieves 100% sustained virologic response rate from an eight week Phase 2 trial evaluating a ribavirin-free regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV), CRMD +8.2% (FDA accepted co's pivotal Phase 3 study protocol), FRO +4.3% (cont strength), SODA +3.7% (following MNST / KO ), GCI +2.3% (Icahn disclosed 6.63% active stake in 13D filing; supports split of the company), BHP +2.2% (announced update on portfolio; demerger of a selection of assets is co's preferred option), GLF +2% (to replace QCOR in the S&P SmallCap 600), DNOW +1.9% (new Berkshire Hathaway stake), PARR +1.9% (announced successful completion of common stock rights offering and award of $164 mln contract with Defense Logistics Agency Energy), MNK +1.9% (completes acquisition of Questcor (QCOR)), GILD +1.5% (disclosed favorable ruling in Roche (RHHBY) / Pharmasset case), CHTR +1% (new Berkshire Hathaway stake), EBAY +0.5% (may soon accept bitcoins at its payment unit, according to reports).

Analyst comments: CHL +2.7% (upgraded to Neutral from Underperform at Mizuho), UPL +1.8% (upgraded to Buy from Neutral at UBS ), GSJK +1.5% (upgraded to Overweight from Neutral at JP Morgan), MBI +1.2% (upgraded to Buy from Neutral at BTIG Research ), NXPI +0.8% (initiated with a Buy at Stifel)

Gapping down
In reaction to disappointing earnings/guidance: ICLD -9%, OPXA -7.8%, PIH -5.7%, PCTY -4.6%, JD -4.4%, JWN -4%, XGTI -3.9%, WB -3.1%, EXTR -1.9%.

Other news: NQ -15.8% ( announces management changes; CFO has resigned from his position for family reasons effective Aug 22, 2014), IDCC -6.7% (co announced it is disappointed with decision by the U.S. International Trade Commission to terminate Investigation No. 337-TA-868), NWBO -5.1% (announced pricing of $17.5 mln offering of convertible notes; convertible at $7.30/share; will fund new manufacturing capacity in Europe), CNAT -3.3% ( filed for a $150 mln mixed securities shelf offering), NEO -2.7% (announced public offering of common stock; size not disclosed), MASI -1.7% (disclosed it received a warning letter from the U.S. FDA regarding compliance with current Good Manufacturing Practices at Masimo's Irvine, CA manufacturing facility.), ZGNX -1.5% (disclosed it received a paragraph IV certification from Actavis (ACT) advising of the filing of an ANDA for a generic version of Zohydro).

Analyst comments: ICPT -2.1% (initiated with a Underperform at FBR Capital; tgt $172 ), KKR -1% (downgraded to Market Perform from Outperform at Wells Fargo), BEBE -0.7% (downgraded to Neutral from Buy at Janney).

Ближайший уровень поддержки по SPY – 194.85 уровень сопротивления – 195.40



ITMN продажа ниже 50

CSIQ продажа от 31

YELP продажа ниже 74

SEAS покупка выще 19

HGR покупка выше 22.50

Gapping up/down: PLUG +7%, PRGO +4% and KSS +2% after earnings; IOC +2% on M&A spec, TSLA +1% after initiation at CS; NDLS -22% and CSCO -1.5% after earnings, SEAS -1% after muliple dg's

Gapping up
In reaction to strong earnings/guidance: PLUG +7%, PRGO +4.2%, AZPN +4.1%, DL +3.5%, NTES +3%, IAG +2.6%, RRGB +2.2%, CASI +2.2%, KSS +1.9%, NTAP +1.8%, RMAX +1.4%, ELP +0.9%, FRSH +0.7%, MTLS +0.5%, SAND +0.5%.

M&A news: IOC +2% (Hearing Bernstein suggesting Exxon (XOM), Total (TOT) and Woodside (WOPEY) as potential InterOil bidders).

Select financial related names showing strength: IRE +2.3%, CS +1.8%, HSBC +1.7%, RBS +1.2%.

Select battery related stocks trading higher after PLUG earnings: FCEL +2.5%, BLDP +2.3%, ZBB +1.4%.

Other news: SUPN +6.5% (receives FDA fast track designation for SPN-810), TCK +3% (still checking), GSL +2.3% (announced pricing of depositary shares representing $35 mln of preferred stock at $25 per share), IQNT +1.9% (increased quarterly dividend 100% to $0.15 from $0.075 per share), PANW +1.9% (cont momentum), PRSC +1.7% (to replace UNS Energy in the S&P SmallCap 600), RSX +1.4% (Pres Putin reportedly will do utmost to end conflict; Interfax reports the Russian govt will adjust list of banned food imports by 8/15), WY +1.4% (increases dividend by 32% and announces $700 mln share repurchase program), TPH +1.3% (positive mention on Mad Money), ZOES +1.1% (upsizes offering by 500K shares and prices 4.5 mln shares of common stock at $30.25), Q +1.1% (positive mention on Mad Money), PCP +1% (Board approved a $1 bln expansion to co's existing share repurchase program).

Analyst comments: ARUN +3% (upgraded to Buy form Hold at Stifel), TSLA +1.3% (initiated with a Outperform at Credit Suisse)

Gapping down
In reaction to disappointing earnings/guidance: NDLS -22.6%, CNAT -11.8%, VCYT -11.6%, TKMR -11.3%, (also — co remains on clinical hold as it relates to the multiple-ascending dose portion of the Phase I clinical study in healthy volunteers with TKM-Ebola, expects matter to be resolved by Q4 2014; co also reported earnings), XONE -9.9%, YUME -9.1%, DGLY -8.7%, VJET -8.2%, OCLR -5.8%, VIPS -3.5%, DANG -3.5%, EXXI -3.3%, AEG -2.4%, CSCO -1.5%, SLW -1.2%, CIG -1.2%.

M&A news: NRG -1% (reaches agreement to acquire Goal Zero; financial terms not disclosed).

Select metals/mining stocks trading lower: RIO -2% ACH -1.9%, SLW -1.2%, CLF -0.9%, BHP -0.7%.

Other news: CNAT -11.8% (co said it is deferring the announcement of top-line results from the Phase 2 NAFLD/NASH clinical trial to Q1 2015; co also reported earnings), FSFR -8% (announced public offering of 22.8 mln shares of common stock), ENPH -5.6% (announced proposed public offering of common stock by selling stockholders), PDII -3.5% (co's subsidiary Interpace Diagnostics entered the molecular diagnostics market with thyroid and pancreatic cancer test portfolio acquisition of miRInform for $8 mln in upfront cash, future commercial milestone-based payments, and royalties), AMH -3.2% (announced public offering of 13 mln shares of Class A common shares), AMGN -2.2% (announced that the Phase 3 clinical trial FOCUS evaluating Kyprolis in patients with relapsed and advanced refractory multiple myeloma did not meet its primary endpoint), TKR -1.9% (announced proposed offering of $300 mln in senior notes due 2024).

Analyst comments: RMTI -4.2% (initiated with a Underperform at FBR Capital), ITMN -3% (downgraded to Neutral from Buy at Goldman), MSG -1.3% (downgraded to Hold at Topeka Capital Markets), SEAS -1.1% (downgraded to Market Perform from Outperform at Wells Fargo, downgraded to Neutral from Buy at BofA/Merrill), FCX -0.9% (downgraded to Hold from Buy at Stifel).

Ближайший уровень поддержки по SPY – 189.75 уровень сопротивления – 191.75



DRC смотрим на продажу

CXO продажа ниже 131

AGN покупка выше 152

SNI покупка выше 77.50

WLP покупка выше 107.50

CI мотрим на продолжение падение

Gapping up 
In reaction to strong earnings/guidance: MELI +14.7%, SHOR +14.5%, ANET +12.2%, AGO +9.2%, BNFT +6.8%, GST +6.6%, MDVN +6.3%, AIRM +5.6%, AL +5.6%, GHDX +5.4%, NOG +4.8%, MHR +4.8%, GPS +4.7%, UBNT +4.6%, NVDA +4.5%, BAGR +4.4%, ELX +4.1%, UEIC +3.8%, AMRN +3.6%, DAR +3.5%, SPPI +2.9%, SCTY +2.8%, VVUS +2.6%, TUMI +2.4%, ZIOP +2.3%, CLNE +1.7%, PGNX +1.7%, CBS +1.4%, MNST +1.4%, WIFI +1%, BIOL +0.9%.

M&A news: TI +4.1% (in discussions with Vivendi (VIVHY)'s GVT regarding merger, according to reports).

Select financial related names showing strength: RBS +3.2%, SAN +2%, UBS +1.7%, DB +1.5%, CS +1.1%, BCS +1%.

Select metals/mining stocks trading higher: SSRI +1.3%, VALE +1.2%, AUY +0.8%, IAG +0.8%, GG +0.6%, GDX +0.4%.

Other news: TKMR +14.9% (FDA Modifies co's TKM-Ebola Clinical Hold to Partial Hold), LULU +5% (confirms lululemon founder Chip Wilson and Advent International announce stock sale and support agreements; will sell ~13.85% of the co's outstanding shares, for ~$845 mln), HZNP +2.7% (Visium Asset Management discloses 5.5% passive stake in 13G filing), FRGI +2.6% (positive mention on Mad Money), MCRL +2.4% (Starboard disclosed 12.0% active stake in 13D filing), JCP +2.2% (positive Mad Money mention), LJPC +1.9% (Tang Capital disclosed 11.4% active stake in 13D filing), PLUG +1.4% (still checking).

Analyst comments: BCRX +4.6% (initiated with a Overweight at JP Morgan), NMBL +1.5% (initiated with a Outperform at Wells Fargo), MNST +1.4% (upgraded to Neutral from Sell at Longbow), ABX +1.3% (added to Conviction Buy list at Goldman), ATVI +0.7% (upgraded to Buy from Neutral at Longbow), EAT +0.5% (upgraded to Outperform from Mkt Perform at Raymond James)

Ближайший уровень поддержки по SPY – 192.25 уровень сопротивления – 193.00



WAG смотрим на рост

PRGO выше 143 покупка

OAS ниже 47 продажа

Gapping up/down: SSYS +12%, MIDD +7%, and SUNE +5% after earnings, select solar names trading higher, LIME +200% after contract win; ATML -5% and COST -1% after earnings/SSS, select metals/miners trading lower
Gapping up 
In reaction to strong earnings/guidance/SSS: SAAS +18.5%, LGP +18.4%, SSYS +12.4%, JACK +11.2%, HZNP +11%, MCP +10.8%, GDP +9.4%, TRMR +8.7%, MBI +7%, MIDD +6.7%, FOXA +5.2%, HAR +5.1%, TPH +4.8%, SUNE +4.8%, DXCM +4.7%, HIMX +4.6%, PKT +4.5%, LDRH +4.5%, EVHC +4.3%, ATHM +4.3%, CRIS +4.2%, QIWI +4.1%, DEG +3.8%, WTI +3.7%, BREW +3.5%, TROX +3.5%, EVRY +3.5%, TDC +3.4%, WWAV +3.3%, KERX +3.2%, DEPO +3.1%, MUSA +2.9%, CTL +2.9%, VNDA +2.9%, WEN +2.8%, JBT +2.6%, OFIX +2.5%, AFSI +2.5%, EXAR +2.4%, RIG +2.3%, RDN +2.3%, PACD +2.2%, DYN +2.2%, ZFGN +2.2%, AGU +2.1%, CSII +2%, ICE +2%, BKD +1.8%, TWO +1.8%, NLY +1.7%, TCAP +1.7%, AAON +1.6%, CDXS +1.5%, WR +1.5%, DNB +1.3%, TEG +1.3%, PMT +1.3%, RIO +1.3%, MRIN +1.2%, RGLD +1.2%, DUK +1.2%, ITMN +1.1%, ETP +1.1%, SN +1.1%, SYMC +1.1%, MNK +1.1%.

M&A news: CST +6.6% (CST Brands (CST) to acquire the general partner of LGP for $17 mln in cash and ~ 2.044 mln shares of CST common stock; CST authorizes repurchase of up to $200 mln of common stock ), NEM +0.8% (exec says company still open to merger with Barrick Gold (ABX), according to reports).

Select solar names showing strength: HSOL +2.9%, JASO +2.4%, TAN +2.4%, TSL +1.8%, CSIQ +1.7%, JKS +1.4%, YGE +1.2%, FSLR +0.7%.

Other news: LIME +203.8% (announced utility program contract win valued at $180 mln), OGXI +23.3% (announces appointment of John Bencich as VP and CFO), LGP +18.4% (CST Brands (CST) to acquire the general partner of LGP for $17 mln in cash and ~ 2.044 mln shares of CST common stock; CST authorizes repurchase of up to $200 mln of common stock ), MCP +10.8% (announces commitment for a $400 mln financing arrangement ), MDCO +10.6% (received FDA approval of Orbactiv (oritavancin) for the treatment of skin infections), CTRP +10% (co and Priceline Group (PCLN) expand partnership; Priceline to make $500 mln investment in Ctrip), GTXI +7.8% (filed for a ~22.156 mln share common stock shelf offering which includes ~10.18 mln shares of its common stock issuable upon the exercise of outstanding warrants, which are held by the selling stockholders), VJET +6.2% (following SSYS results), CTIC +6.1% (receives FDA Fast Track Designation for Pacritinib, a novel JAK2 Inhibitor for the treatment of myelofibrosis), XONE +5.9% (following SSYS results), PERY +4.9% (following late move higher on volume — attributed to M&A speculation), DDD +3.4% (following SSYS results), WBAI +2.1% (enters into strategic partnership with China Mobile Limited (CHL)), DB +2% (peer Commerzbank trading higher after results), VMW +1.7% (announced authorization of stock repurchase program of up to $1 bln of its Class A common stock), BKS +1.5% (Google and Barnes & Noble (BKS) want to compete with Amazon (AMZN) on speedy book delivery, according to reports), MNK +1.1% (announced settlement of OFIRMEV (acetaminophen) injection patent litigation with Fresenius Kabi USA), BAC +0.9% (reports suggesting $16.5 bln DoJ settlement).

Analyst comments: AOL +3.3% (upgraded to Buy from Hold at Cantor Fitzgerald), CCL +2.1% (upgraded to Buy from Neutral at BofA/Merrill), ANR +1.6% (upgraded to Neutral from Sell at UBS), ARMH +1.3% (upgraded to Buy from Hold at The Benchmark Company), WAG +1% (upgraded to Hold from Sell at Cantor Fitzgerald)

Gapping down
In reaction to disappointing earnings/guidance/SSS: THOR -26.4%, ELON -17%, BWC -12.6%, GEOS -9.5%, RNDY -9.5%, ANAD -9.1%, IO -8.4%, CSOD -8.2%, COUP -7.6%, TXTR -6.6%, OSUR -6%, TNGO -5.4%, ATML -5.2%, ATRS -5.2%, FTK -5.1%, ZEUS -4.9%, PHMD -4.7%, ERII -4.6%, CLDX -4.5%, ZU -4.5%, SD -4.5%, NVAX -4.1%, GPOR -3.9%, IXYS -3.9%, DVAX -3.9%, DRTX -3.7%, WIN -3.5%, CPA -3.3%, EVC -3.2%, NIHD -3.2%, BDBD -3%, CECE -3%, LAMR -3%, RDUS -2.8%, SABR -2.8%, IDCC -2.7%, FRED -2.6%, ACAS -2.4%, GMCR -2.2%, TSE -2.2%, SRPT -2%, MWE -1.9%, DSCI -1.9%, AUXL -1.8%, HIL -1.6%, MYL -1.6%, HRC -1.6%, YY -1.5%, CXW -1.5%, PRSC -1.5%, TOPS -1.5%, AGYS -1.4%, CPE -1.3%, LPI -1.3%, PHX -1.3%, CGI -1.1%, NVTL -1.1%, CTB -1%, MPEL -1%, COST -1%.

Select metals/mining stocks trading lower: TC -2.2%, AU -1.5%, AU -1.5%, HL -1.2%, HL -1.2%, IAG -1.1%, HMY -1%, BHP -0.5%, MT -0.4%.

Other news: NYMX -8% (Paul Averback sold in a private transaction for financial planning purposes 470,600 common shares of NYMX for a total consideration of $2.4 mln), UMPQ -3.5% (announces secondary offering of 15 mln shares held by Thomas H. Lee Partners and Warburg Pincus), SHPG -1.8% (still checking), PT -1.5% (still checking), YY -1.5% (Shanghai -1.3% overnight), EBS -1.3% (submits Biologics license application to FDA for Anthrax Immune Globulin Intravenous), ASTM -0.9% (filed for a $20 mln common stock offering), RSPP -0.8% (announces pricing of 10 mln shares of common stock offering at $25.65/share).

Analyst comments: NUS -0.6% (downgraded to Neutral from Overweight at JP Morgan), AET -0.6% (downgraded to Neutral from Buy at Goldman), UNH -0.6% (removed from Conviction Buy list at Goldman), PERI -0.5% (downgraded to Hold from Buy at Needham), VOD -0.4% (downgraded to Mkt Perform from Outperform at Raymond James).

Описание вебинара
Опытный трейдер Дмитрий Гаврилов уверен: зарабатывать можно не только утром, но и в спокойное время, когда на рынке меньше риска и больше трендовых движений. Чем руководствоваться при отборе акций в обед? Какими фильтрами пользоваться? Как находить наиболее перспективные акции? На эти и другие вопросы ответит автор вебинара и на примерах покажет участникам, на что стоит обращать внимание при выборе акций для торговли.

Описание вебинара
Краткий рассказ о торговой стратегии. 
Анализ утреннего движения рынка. 
Инструменты для отбора акций. 
Разбор предложенных акций слушателей.
Особенности вебинара
Занятие проводится компанией GT Capital Group.

Ведущий вебинара – Дмитрий Гаврилов, успешный трейдер на фондовых биржах США. Торгует с 2008 года. С 2009 года старший трейдер и групп-лидер. Более трех лет профессионального обучения трейдеров. В 2011 году стал партнером компании GT Capital Group.

Ближайший уровень поддержки по SPY – 191.00 уровень сопротивления – 192.25



SNCR покупка выше 42, ниже продажа

CRR покупка выше 106

SALE при удержании 18 покупка, ниже продажа

AGN следим за акцией

BLMN покупка при удержании 15

Ближайший уровень поддержки по SPY – 192.80 уровень сопротивления – 193.75



PDCE следим за ней, возможен шорт

ALR покупка выше 35

KORS покупка от 76

Gapping up/down: COH and ODP +6% after earnings, MNI, GCI and ACH trading higher on M&A news; BLMN and IHG -4% after earnings, PNRA -2% after CFO resigns

Gapping up 
In reaction to strong earnings/guidance: NLS +12.8%, GTAT +10.4%, AKRX +7%, COH +6.2%, CHGG +6.1%, ODP +5.7%, EPAM +4.4%, CAR +4.2%, JMBA +4.2%, CRZO +4%, TSRA +3.8%, ANV +3.7%, ANSS +3.2%, MWA +3.1%, ELNK +3.1%, ARQL +3.1%, REGI +2.6%, KFRC +2.4%, ARCO +2.3%, AIG +2.1%, WLK +2.1%, MRO +2%, MGM +1.8%, VSI +1.4%, THC +1.3%, CVS +1.3%, KWK +1.1%, BCRX +1%,.

M&A news: MNI +12.7% (announces agreement to sell its 25.6% stake in Cars.com to Gannett (GCI)), GCI +6.4% (MNI announces agreement to sell its 25.6% stake in Cars.com to Gannett (GCI)), AHC +6.2% (A.H. Belo to sell its units in Classified Ventures to Gannett (GCI) for a price that values CV at $2.5 bln; remains Cars.com reseller).

Select solar stocks trading higher: YGE +2.8%, TSL +2.8%, CSIQ +2%, FSLR +1.7%, HSOL +1.1%, SUNE +0.7%, JKS +0.3%.

Other news: BAXS +25% (announces 2 new patents for VEO direct lateral and AxiaLIF minimally invasive interbody fusion systems), USU +8% (disclosed an amendment to its agreement with the Department of Energy that provides for additional funds of ~$5.7 mln), ZNGA +1.8% (still checking), P +1.7% (may launch Talk Radio for cars, according to reports out yesterday afternoon), GRPN +1.3% (still checking), TASR +1.2% (reports orders for hundreds of AXON Cameras for July),.

Analyst comments: HIMX +4.5% (upgraded to Buy from Neutral at BofA/Merrill), SERV +3.5% (initiated with a Overweight at Piper Jaffray), ADHD +2.3% (initiated with a Overweight at Piper Jaffray), FMS +1.8% (upgraded to Buy from Neutral at UBS), THC +1.3% (upgraded to Neutral from Negative at Susquehanna)

Gapping down
In reaction to disappointing earnings/guidance: FIVN -27%, SALE -23.9%, END -12.8%, LF -6.8%, MSI -6.4%, ECOM -5.3%, CTIC -4.8%, BLMN -4.1%, IHG -3.9%, MDR -3.6%, ROSE -3.3%, GTXI -3.3%, SYKE -3.1%, OESX -3%, WAIR -2.7%, ACT -2.6%, CNQR -2.3%, REGN -2.2%, DRC -2%, AREX -1.9%, CNK -1.9%, RHP -1.9%, ALLT -1.8%, PXD -1.5%, TGT -1.3%, ENH -1.2%, HCLP -1%.

M&A news: TEF -0.7% (TEF launches acquisition offer for Vivendi's (VIV) GVT unit), VIV -0.2% (TEF launches acquisition offer for Vivendi's (VIV) GVT unit).

Select EUrelated names showing weakness: ALU -3.5%, DB -2.6%, UBS -1.6%, ARMH -1.1%, BCS -0.9%.

Other news: DRAM -3.1% (pulling back from yesterday's move), STAY -2.2% (announced launch of secondary offering by selling shareholder), PNRA -2% (announced CFO departure; Bill Moreton, Executive Vice Chairman and former CEO, to serve as interim CFO), ESI -1.4% (announced that CEO Kevin M. Modany intends to resign, effective February 4, 2015; John Dean named Executive Chairman; Eugene Feichtner promoted to President and COO), BHP -1.1% (potentially related to weaker than expected Aus Trade Balance), BERY -1% (announced 14,728,218 share secondary public offering by certain funds affiliated with Apollo Global Management).

Ближайший уровень поддержки по SPY – 192.85 уровень сопротивления – 193.10



TMST, LOCO смотрим на покупку недавнее IPO

OCN смотрим на покупку при удержании 27.50

Gapping up/down: KORS +3.3%, HSBC +1.8%, BRK.B +1.5% on earnings, PIKE +47.7% on M&A, Drug/biotech names higher… oil/gas related names lower

Gapping up:
In reaction to strong earnings/guidance: KORS +3.3%, HSBC +1.8%, BRK.B +1.5%.

M&A related: PIKE +47.7% (Pike Shareholders to receive cash of $12.00 per share in transaction led by Court Square Capital Partners), EVR +1.7% (following late weakness — Evercore confirmed plans to to acquire ISI Group and the remaining 40% interest in Evercore's Institutional Equities business; co will issue up to ~ 8 mln share equivalents in the two transactions; transaction expected to be accretive to Adjusted Pro Forma EPS in first year and has potential to be meaningfully accretive starting in 2016), GSK +1% SNY +0.5% (PE firms may purchase older drug brands of GSK and Sanofi (SNY), according to reports),

Drug names/biotech trading higher: TKMR +34.9% (strength attributed to Ebola related fears/plan), LGND +8% (still checking), AZN +0.9% (higher despite reports indicating Hedge funds betting against AZN takeover bid ), ANIP +2.4% (acquires Vancocin capsules and additional vancomycin assets from Shire ), AMGN +1.3% (announces Phase 3 ASPIRE trial of Kyprolis In Patients With Relapsed Multiple Myeloma met primary endpoint; Kyprolis helped patients Live 8.7 months longer without their disease worsening)

Other news: PT +4.8% (traded higher overseas), LOCO +3.9% (still checking), MBLY +3.2% (continued strength/volatility from IPO), DHI +2.9% ( ticking higher on positive Barron's story), INFY +2.8% (traded higher overseas on weaker rupee), EMC +1.2% (Barron's profiles positive view), GPRO +1% (still checking), AAPL +0.8% (still checking), LOGI +0.8% (still checking), SCTY +0.7% (appoints semiconductor veteran Brad Buss as CFO), HLF +0.6% (Barron's report defends name), PSEC +0.6% (exits AirMall at a gross 16.7% internal rate of return and 1.61x cash-on-cash return).

Analyst comments: HIMX +4.3% (upgraded to Buy from Hold at Lake Street), BYI +2.7% (upgraded to Neutral from Sell at Goldman), X +2% ( upgraded to Buy from Hold at Deutsche Bank; upgraded to Buy from Hold at KeyBanc Capital Mkts ), MT +1% (upgraded to Neutral at Exane BNP Paribas), VOD +1% (upgraded to Buy from Neutral at Redburn ), ALU +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley), STLD +0.4% (upgraded to Buy from Hold at KeyBanc Capital Mkts), OXY +0.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $120 from $110)

Gapping down:
In reaction to disappointing earnings/guidance: AN -5%, SNH -3.5% (light volume).

Select oil/gas related names showing early weakness: NE -12.2% (downgraded to Hold from Buy at Deutsche Bank), DO -4.9% (downgraded to Sell from Hold at Deutsche Bank), RIG -2.3% (downgraded to Sell from Hold at Deutsche Bank), CVX -0.9%, SDRL -0.9%, CVX -0.4% (downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $140 from $135).

Other news: INSM -20.3% (provides regulatory update for ARIKAYCE; Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications; confirms US development plan for NTM Following FDA guidance), ZGNX -7% (announces Departure of Chief Commercial Officer), ARMH -2.2% (still checking), VNR -1.5% (to acquire natural gas, oil and natural gas liquids assets in North Louisiana and East Texas for $278 mln from Hunt Oil; immediately accretive to distributable cash flow at closing, TWTR -1.2% (reports that users do not view ads), CCL -1.2% (still checking), JPM -0.8% (has reached a $4.5 bln mortgage trust related settlement, according to reports), DAN -0.7% ( announces additional $400 million share repurchase authorization, pays dividends on common stock and final dividends on series b convertible preferred stock) QCOR -0.5% ( Institutional Shareholder Services Inc. and Glass Lewis recommend that shareholders of Mallinckrodt and Questcor vote for Mallinckrodt's acquisition of Questcor), SODA -0.4% ( Soros liquidated stake, according to reports), MCD -0.3% (to resume full China menu in some cities this week, according to reports).

Analyst comments: DEI -1.2% (downgraded to Sell from Hold at Stifel ), AEP -0.6% (downgraded to Equal Weight from Overweight at Morgan Stanley), RPXC -0.6% (downgraded to Equal Weight from Overweight at Barclays), QLGC -0.2% ( downgraded to Equal Weight from Overweight at Barclays )

Ближайший уровень поддержки по SPY – 195.50 уровень сопротивления – 196.10



X смотрим на продажу

LACI продажа от 70